[go: up one dir, main page]

LT2624865T - Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies - Google Patents

Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Info

Publication number
LT2624865T
LT2624865T LTEP11770625.9T LT11770625T LT2624865T LT 2624865 T LT2624865 T LT 2624865T LT 11770625 T LT11770625 T LT 11770625T LT 2624865 T LT2624865 T LT 2624865T
Authority
LT
Lithuania
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
LTEP11770625.9T
Other languages
Lithuanian (lt)
Inventor
Daniel Dix
Xiaolin Tang
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Priority claimed from PCT/US2011/054856 external-priority patent/WO2012047954A1/en
Publication of LT2624865T publication Critical patent/LT2624865T/en

Links

LTEP11770625.9T 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies LT2624865T (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
LT2624865T true LT2624865T (en) 2018-10-25

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11770625.9T LT2624865T (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Country Status (14)

Country Link
AR (1) AR083338A1 (en)
DK (2) DK2624865T3 (en)
ES (2) ES2820246T3 (en)
HK (1) HK1258305A1 (en)
HR (1) HRP20181822T1 (en)
HU (1) HUE052089T2 (en)
LT (1) LT2624865T (en)
PT (1) PT3354280T (en)
RS (1) RS57850B1 (en)
SI (1) SI2624865T1 (en)
SM (1) SMT201800488T1 (en)
TW (7) TWI498121B (en)
UA (1) UA111731C2 (en)
UY (1) UY33652A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015003590A8 (en) 2012-08-21 2017-10-31 Sanofi Sa METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTRATION OF AN IL-4R ANTAGONIST
HUE046410T2 (en) * 2013-06-21 2020-03-30 Sanofi Biotechnology Methods for treating nasal polyposis by administering an il-4r antagonist
AU2014284235B2 (en) * 2013-06-21 2019-11-21 Regeneron Pharmaceuticals, Inc. Methods for treating nasal polyposis by administering an IL-4R antagonist
WO2016077675A1 (en) 2014-11-14 2016-05-19 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
PL3703818T3 (en) 2017-10-30 2024-03-25 Sanofi Biotechnology Il-4r antagonist for use in a method for treating or preventing asthma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (en) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% PATTERN ALIGNMENT SYSTEM IN A SUBSTRATE BY LITOGRAPHY BY ESTENCIL.
KR101593726B1 (en) * 2008-09-10 2016-02-18 니혼 엑스란 고교 (주) Crosslinked acrylate-based fibers and the production thereof
CA2754528A1 (en) * 2009-03-06 2010-09-10 Genetech, Inc. Antibody formulation

Also Published As

Publication number Publication date
HK1258305A1 (en) 2019-11-08
TW201716086A (en) 2017-05-16
TW202320851A (en) 2023-06-01
PT3354280T (en) 2020-09-01
HUE052089T2 (en) 2021-04-28
DK3354280T3 (en) 2020-09-28
SMT201800488T1 (en) 2018-11-09
TW202026011A (en) 2020-07-16
TWI690329B (en) 2020-04-11
TW202102262A (en) 2021-01-16
UY33652A (en) 2012-04-30
TWI856388B (en) 2024-09-21
TW201221141A (en) 2012-06-01
RS57850B1 (en) 2018-12-31
ES2687813T3 (en) 2018-10-29
HRP20181822T1 (en) 2018-12-28
ES2820246T3 (en) 2021-04-20
TWI718890B (en) 2021-02-11
TW201542229A (en) 2015-11-16
TWI498121B (en) 2015-09-01
TWI782325B (en) 2022-11-01
SI2624865T1 (en) 2018-10-30
TWI679988B (en) 2019-12-21
DK2624865T3 (en) 2018-10-22
TW201924718A (en) 2019-07-01
AR083338A1 (en) 2013-02-21
UA111731C2 (en) 2016-06-10
TWI568445B (en) 2017-02-01

Similar Documents

Publication Publication Date Title
IL283424B1 (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
HRP20181821T1 (en) Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
IL265501B (en) Stabilized antibody-containing liquid formulations
RS61082B1 (en) Stable antibody containing compositions
HK1258305A1 (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
EP2588141A4 (en) Antibody formulations